Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results

Patricia H. Hardenbergh(Duke Medical Center), Michael T. Munley(Duke Medical Center), Gunilla C. Bentel(Duke Medical Center), Ronit Kedem(Duke Medical Center), Salvador Borges‐Neto(Duke Medical Center), Donna Hollis(Duke University), Leonard R. Prosnitz(Duke Medical Center), Lawrence B. Marks(Duke Medical Center)

International Journal of Radiation Oncology*Biology*Physics

March 1, 2001

10.1016/s0360-3016(00)01531-5

Cited by 176

Abstract

Related Papers

Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

Daniel D. Von Hoff, MAXWELL W. LAYARD, PETER BASA et al.|Annals of Internal Medicine|1979|2.4k

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer

Joseph Ragaz, Stewart M. Jackson, Nhu Le et al.|New England Journal of Medicine|1997|1.8k

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

Steven E. Lipshultz, Steven D. Colan, Richard D. Gelber et al.|New England Journal of Medicine|1991|1.4k

Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease

Steven Hancock|JAMA|1993|748

Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer

Lars Erik Rutqvist, Ingmar Lax, Tommy� Fornander et al.|International Journal of Radiation Oncology*Biology*Physics|1992|393